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Folding and post-translational modification of the
thyroid hormone precursor, thyroglobulin (Tg), in the
endoplasmic reticulum (ER) of the thyroid epithelial
cells is facilitated by several molecular chaperones and
folding enzymes, such as BiP, GRP94, calnexin, protein
disulfide isomerase, ERp72, and others. They have been
shown to associate simultaneously and/or sequentially
with Tg in the course of its maturation, thus forming
large heterocomplexes in the ER of thyrocytes. Here we
present evidence that such complexes include a novel
member, an ER-resident lumenal protein, ERp29, which
is present in all mammalian tissues with exceptionally
high levels of expression in the secretory cells. ERp29
was induced upon treatment of FRTL-5 rat thyrocytes
with the thyroid-stimulating hormone, which is essen-
tial for the maintenance of thyroid cells and Tg biosyn-
thesis. Chemical cross-linking followed by the cell lysis
and immunoprecipitation of ERp29 or Tg revealed asso-
ciation of these proteins and additionally, immunocom-
plexes that also included major ER chaperones, BiP and
GRP94. Sucrose density gradient analysis indicated co-
localization of ERp29 with Tg and BiP in the fractions
containing large macromolecular complexes. This was
supported by immunofluorescent microscopy showing
co-localization of ERp29 with Tg in the putative trans-
port vesicular structures. Affinity chromatography us-
ing Tg as an affinity ligand demonstrated that ERp29
might be selectively isolated from the FRTL-5 cell lysate
or purified lumenal fraction of rat liver microsomes
along with the other ER chaperones. Preferential asso-
ciation with the urea-denatured Tg-Sepharose was in-
dicative of either direct or circuitous ERp29/Tg interac-
tions in a chaperone-like manner. Despite the presence
of the C-terminal ER-retrieval signal, significant
amounts of ERp29 were also recovered from the culture
medium of stimulated thyrocytes, indicating ERp29 se-
cretion. Based on these data, we suggest that the func-
tion of ERp29 in thyroid cells is connected with folding
and/or secretion of Tg.
Proper folding, post-translational modifications, and oli-
gomerization of the secretory proteins in the endoplasmic re-
ticulum (ER)1 are essential prerequisites for their recruitment
into the transport vesicles heading toward the cell exterior (1).
Quality control of potential cargo proteins is accomplished by
the molecular chaperones that monitor fidelity of the protein
folding and prevent premature export of incorrectly folded or
incompletely assembled secretory proteins from the ER (2).
Circumstantial evidence, such as inducibility in certain cell
types under the ER stress conditions (3), high expression in the
secretory tissues (4, 5), and co-localization with the ER chap-
erones (3), suggests that a recently discovered, ubiquitously
expressed endoplasmic reticulum lumenal protein, ERp29, may
complement this group of ER chaperones.
ERp29 cDNA was originally cloned from the rat liver (3, 6) and
enamel cells (7), and the ERp29 gene was shown to be highly
conserved in all studied mammalian species (3–5). For instance,
rat ERp29 and its human ortholog, originally termed ERp28 (8),
are 90% identical on the amino acid sequence level (9).
ERp29 consists of two domains of which the N-terminal
domain of ERp29 resembles the thioredoxin module of protein
disulfide isomerase (PDI), although without the active site
double cysteines, indicating the lack of PDI-like redox function
(9). The C-terminal domain represents a novel all-helical fold
that is absent in human PDI but found in the P5-like PDIs and
also in the Drosophila analog of ERp29, Windbeutel (10). The
function of this domain remains unclear, although its C-termi-
nal sequence, KEEL, which is a conserved variant of the ER
retrieval signal, KDEL (11), most probably confers ER reten-
tion to ERp29.
Recently the ERp29 gene has been shown to be activated upon
the treatment of rat thyroid epithelial cells by the thyroid-
stimulating hormone (TSH) (12). The latter is essential for the
optimal growth of thyrocytes and expression of thyroid-specific
genes including the gene encoding a thyroid prohormone thyro-
globulin (Tg), a 660-kDa homodimeric secretory protein (13). The
proper folding and assembly of the transport-competent Tg
dimers is controlled by the major ER molecular chaperones and
folding enzymes, such as BiP, GRP94, calnexin, ERp72, and PDI.
Simultaneous and/or sequential interactions of Tg with such
helper proteins lead to the transient formation of the large mac-
romolecular heterocomplexes in the ER (14–16).
A high level of ERp29 gene expression in thyrocytes (5) and
its transcriptional regulation by TSH (12) suggested that
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ERp29 may be implicated, along with other ER chaperones, in
the maturation and/or secretion of Tg. Therefore we carried out
immunoprecipitation of ERp29 and Tg, sucrose density gradi-
ent fractionation of the cross-linked thyrocytes, and affinity
chromatography on the denatured Tg-Sepharose, which indi-
cated involvement of ERp29 in the heterogeneous Tg folding
complexes. Moreover, we found co-localization of ERp29 with
Tg in the putative intracellular transport structures as evi-
denced by immunofluorescence microscopy and, additionally,
secretion of considerable amounts of ERp29 from thyrocytes.
These findings for the first time suggest a distinct function for
ERp29 connected with the folding and/or export of secretory
proteins.
EXPERIMENTAL PROCEDURES
Cell Culture—FRTL-5 Fisher rat thyrocytes were cultivated in the
Coon’s modified Ham’s F-12 medium containing 10% fetal bovine serum
(Invitrogen) with the addition of the six-hormone (6H) mixture: thyro-
tropin (TSH) (1 milliunit/ml), transferrin (5 g/ml), somatostatin (10
ng/ml), glycyl-1-histidyl-1-lysine (10 ng/ml), hydrocortisone (10 nM), and
insulin (10 g/ml). All of the hormones were purchased from Sigma.
Isolation of the Lumenal Fraction of the Rat Liver Microsomes—The
microsomes were isolated from the livers of male Sprague-Dawley rats
as described in detail elsewhere (17). They were subsequently washed
in 100 mM sodium pyrophosphate, pH 7.4, resuspended in 20 mM Tris-
HCl, 1 mM dithiothreitol, 150 mM NaCl, pH 8.0, and sonicated. Solubi-
lized microsomes were recentrifuged at 100,000  g, and the superna-
tant was designated as a lumenal fraction.
Metabolic Labeling and Immunoprecipitation—The cells were grown
with or without the 6H mixture 3 days prior to the experiment, washed
with PBS, incubated for 1 h in the methionine-free medium, and
labeled with 100 Ci/ml [35S]methionine (Amersham Biosciences) for
4 h. The cells were washed twice with PBS and cross-linked with the
200 g/ml of the homobifunctional, thiol-cleavable, membrane-perme-
able agent, DSP (Pierce) in PBS at room temperature for 30 min. The
reaction was stopped by the 100 mM Tris-HCl, pH 7.5, and the cells were
lysed by the 1% Triton X-100 in PBS containing protease inhibitors
mixture (“Complete,” Roche Molecular Biochemicals) for 15 min,
scraped, and centrifuged for 10 min at 17,000  g. The ensuing super-
natant was used for the immunoprecipitations with the polyclonal
anti-ERp29 IgGs conjugated with the BrCN-Sepharose (Amersham Bio-
sciences) or polyclonal anti-human Tg (Dako) for 16 h. 25% protein
A-Sepharose was added to the samples treated with anti-Tg and incu-
bated for 1 h. The immunocomplexes were washed three times with the
lysis buffer and once in PBS and water and eluted by the SDS-PAGE
sample buffer with the subsequent reducing SDS-PAGE. The proteins
were transferred to the nitrocellulose membrane and analyzed by the
Fuji BAS-1800 phosphoimager.
Sucrose Density Gradient—Cross-linked or control FRTL-5 cell ly-
sates including protease inhibitors were layered on top of the discon-
tinuous 5–20% sucrose gradients prepared in PBS (six 1-ml layers with
the 3% sucrose increments) and centrifuged for 16 h in the Beckman
SW40TI swing-out rotor at 100,000  g. The centrifuge tubes were
punctuated in the bottom, and 12  0.5-ml fractions were collected and
precipitated by 10% (final concentration) trichloroacetic acid. The pel-
lets were washed by ice-cold acetone, resuspended in the SDS-PAGE
sample buffer, and analyzed by reducing SDS-PAGE followed by West-
ern blot.
Affinity Chromatography—Affinity interactions with thyroglobulin
and histone ligands were scrutinized as in Ref. 15 with minor modifi-
cations. FRTL-5 cell lysate (2  106 cells) or lumenal fraction (50 g
of protein) of the rat liver microsomes was incubated for 16 h at 4 °C on
the rotating wheel with 50 g (wet weight) of nondenatured or dena-
tured (30 min in 6 M urea and 1 M -mercaptoethanol) Tg- or histone-
Sepharose beads (Sigma) in the binding buffer consisting of 20 mM
Tris-HCl, 150 mM NaCl, 1 mM dithiothreitol, and protease inhibitors
mixture, pH 8.0. The beads were subsequently washed with 2 ml of the
same buffer and eluted with 0.5 ml of 1 mM ATP in the binding buffer
including 2 mM MgCl2 and 0.5 mM CaCl2, followed by boiling for 1 min
in the 50 l of SDS solubilization buffer. Flow-through, wash, and ATP
eluate fractions were concentrated by acetone precipitation and dis-
solved in the SDS solubilization buffer. All of the fractions were ana-
lyzed by SDS-PAGE with subsequent immunoblotting.
Western Blot—The proteins were resolved by SDS-PAGE, trans-
ferred to the nitrocellulose membrane, and probed with antibodies
against ERp29 (3), Tg, BiP (anti-peptide rabbit polyclonals, StressGen),
GRP94 (rat monoclonals, StressGen), PDI, (monoclonals, Affinity
BioReagents), and mitochondrial HSP70 (polyclonals; Affinity BioRe-
agents). Immunoreactive bands were visualized by the SuperSignal
enhanced chemiluminescence according to the manufacturer’s specifi-
cations (Pierce) using luminescent image analysis system LAS 1000
(Fujifilm).
Immunofluorescent Microscopy—FRTL-5 cells were grown in the me-
dium containing the 6H mixture on coverslips to 30–40% confluency,
washed twice with PBS, and fixed for 10 min in 2% formaldehyde
followed by a brief rehydration in PBS. The cells were permeabilized for
FIG. 1. Induction of ERp29 and ER chaperones by hormones.
FRTL-5 cells were grown with or without the hormonal mixture (6H) to
70–80% confluency. The cells were subsequently lysed, electrophore-
sed, and immunoblotted with corresponding antibodies. Equal amounts
of total protein were applied to each lane.
FIG. 2. ERp29 association with Tg and chaperones. FRTL-5 cells
were treated as indicated in the legend to Fig. 1, labeled with [35S]me-
thionine for 4 h, and cross-linked with DSP, and the cell lysates repre-
senting equal amounts of total labeled proteins were immunoprecipi-
tated with BrCN-immobilized ERp29 polyclonal IgGs, polyclonal
anti-Tg (Tg), or preimmune rabbit serum (PI). The proteins were re-
solved by 8.5% reducing SDS-PAGE and transferred to the nitrocellu-
lose membrane. The identities of co-immunoprecipitated BiP, GRP94,
and Tg were confirmed by immunoblotting (results not shown). A,
autoradiograph of the membrane. B, Western blot analysis of the same
membrane using ERp29-specific antibodies.
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10 min in 0.2% Triton X-100, washed with TBS, and subsequently
probed with primary antibodies in 2% bovine serum albumin, 0.02%
Tween 20, 10% glycerol in PBS for 30 min. After five 2-min washes with
PBS, the cells were incubated for 30 min with fluorochrome-conjugated
secondary antibodies (Sigma) and washed again with PBS. DNA was
stained by Hoechst 33258 (Sigma). All of the incubations were carried
out at room temperature. For in vivo staining, the cells were fixed and
incubated with primary and secondary antibodies in the humidified
CO2-incubator at 37 °C. The coverslips were mounted with Vectra-
shield. Optical sectioning and three-dimensional reconstitution were
carried out using a Zeiss Axiophot microscope. The images were cap-
tured with a PXL cooled CCD camera (Photometrix). Image processing
was provided by the imaging program ST-FITC-Rhodamine-Hoecsht-
bin1 (18), which produces both single and stereo-projected three-color
images from a series of wide field pictures where the out-of-focus blur
was removed by nearest neighbor deconvolution and the images were
built up using a maximum intensity projection algorithm.
RESULTS
ERp29 Is Induced upon Stimulation of Thyrocytes—Stimu-
lation of FRTL-5 cells by the mixture of six hormones including
TSH revealed an approximately 2-fold increase of the immuno-
detectable ERp29 in accordance with the previously reported
induction of mRNA synthesis under the same conditions (12)
(Fig. 1). BiP, GRP94, and PDI levels where also elevated 2–3-
fold as seen before (19, 20), whereas the amount of the mito-
chondrial HSP70 remained unchanged, indicating the specific-
ity of the effect for the ER (Fig. 1). TSH alone was able to cause
similar induction of ERp29 and ER chaperones in a dose-de-
pendent manner, although the effect was less pronounced (re-
sults not shown).
ERp29 Associates with Tg, BiP, and GRP94—Concerted up-
regulation of ERp29 and ER chaperones suggests a putative
chaperone-related function for ERp29, in which case its asso-
ciation with the nascent Tg molecules might be expected. To
investigate this possibility, we have immunoprecipitated Tg
and ERp29 from the quiescent and 6H mixture-grown thyroid
cells, which were metabolically labeled and chemically cross-
linked prior to the lysis.
Anti-Tg co-precipitated BiP and GRP94 (the latter appeared
in the Tg immunocomplexes only upon cross-linking) (16, 20).
The amounts of these chaperones associated with Tg were
further enhanced by hormonal stimulation (Fig. 2A, lanes 2, 5,
8, and 11). In addition, Tg immunocomplexes from the 6H
mixture-grown and cross-linked cells display a weak labeled
band migrating at the level of 29 kDa. Immunoblotting ex-
periments revealed its identity as ERp29 (Fig. 2B). Moreover,
an ERp29-immunoreactive band was seen also in the cross-
linked quiescent cells (Fig. 2B, lane 5). Thus, ERp29 appears to
be a member of the Tg-containing heterocomplexes that also
include BiP and GRP94. The complex formation was signifi-
cantly enhanced by the hormone stimulation. The appearance
of ERp29 band on the autoradiographs was relatively weak,
either because of a weak association of ERp29 with Tg or
because of the insufficient 35S labeling of ERp29. However,
Western blotting demonstrated rather strong immunoreactive
staining.
The authenticity of the presented data was examined by
immunoprecipitation experiments using ERp29 antibodies. Al-
though the control cell lysates did not contain any co-precipi-
tating Tg, a conspicuous Tg band appeared in the stimulated
cells, which was additionally enhanced by DSP (Fig. 2A, lanes
7 and 10). Moreover, the immunocomplexes from the cross-
linked samples precipitated by anti-ERp29 contained BiP and
GRP94 similar to the Tg complexes (same lanes), and the
appearance of GRP94 was dependent on the cross-linking as in
the case of Tg immunoprecipitation. This indicates weak inter-
actions of these proteins in the ER.
Because ATP is required for the dissociation of Tg from BiP
(15) and some other chaperones, we immunoprecipitated Tg in
the presence of 2 mM Mg/ATP or 50 units/ml apyrase/5 mM
EDTA. The amount and content of Tg immunocomplexes re-
mained unaltered (results not shown), indicating that ERp29
interaction(s) in the Tg multipartite complex is (are) ATP-
independent. This is consistent with an earlier report where no
FIG. 3. Sucrose density gradient
analysis of ERp29, BiP, and Tg in the
cross-linked thyrocytes. FRTl-5 cells
were grown in the 6H-containing medium
to 70–80% confluency, cross-linked by
DSP, lysed, layered on the top of the
5–20% sucrose gradient, and centrifuged
to equilibrium. Twelve fractions were col-
lected, and proteins were precipitated by
trichloroacetic acid treatment and ana-
lyzed by 8.5% reducing SDS-PAGE fol-
lowed by Western blot.
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ATP binding to ERp29 was found under in vitro conditions (8).
Co-immunoprecipitation of ERp29 with Tg and ER chaper-
ones suggests the existence of the transient high molecular
weight folding complexes in the ER. To examine this possibil-
ity, control and cross-linked FRTL-5 cells lysates were fraction-
ated using sucrose density gradient centrifugation, and the
resulting fractions were analyzed for the presence of ERp29,
BiP, and Tg.
Tg was detected in the higher molecular weight fractions
(Fig. 3, lanes 3–5) and was further shifted toward denser frac-
tion (lane 2) upon cross-linking. Interestingly, a similar shift
was observed also with ERp29 and BiP. In DSP-treated cells, a
significant amount of ERp29 was distributed throughout the
gradient with a conspicuous peak in the fraction 2, correspond-
ing to the highest amount of Tg detected in the cross-linked
sample. Relatively low levels of ERp29 in this fraction are
consistent with a small amount of ERp29 co-immunoprecipi-
tated with Tg. BiP was distributed more widely in the fractions
obtained from the intact cells, which indicates more stable
interactions in the complexes with different substrate proteins
and/or ER chaperones. In line with these data, significant
amounts of BiP were co-immunoprecipitated with Tg even from
noncross-linked cells (Fig. 2). DSP treatment led to the further
redistribution of BiP toward the heavier fractions with a peak
detected in the fractions 1–2, also containing high amounts of
Tg and ERp29.
ERp29 Interacts with Denatured Tg—To investigate further
possible interactions of ERp29 within Tg complexes in the ER,
we employed affinity chromatography using native or dena-
tured protein ligands such as thyroglobulin and histone cou-
pled with a Sepharose matrix. It has been shown earlier that
several ER chaperones and folding catalysts bind with high
specificity to immobilized denatured Tg, histone, and other
proteins (15). Many ER chaperones are ATP-binding proteins,
and it was demonstrated that ATP hydrolysis is essential for
the dissociation of BiP from its substrates (21). Thus, FRTL-5
cell lysate was allowed to bind to the denatured Tg-Sepharose
in the batch adsorption manner, eluted first with 1 mM ATP
and then with the SDS solubilization buffer. Ensuing fractions
were tested for the presence of ERp29, BiP, and PDI.
In spite of the fact that the majority of ERp29 was found in
the flow-through fraction, significant amounts were also de-
tected in the SDS eluate, indicating its interaction with the
affinity matrix (Fig. 4A). ATP was unable to dissociate ERp29
from the immobilized Tg. BiP was also found associated with
the Tg-Sepharose and was eluted with ATP, although large
amounts of protein remained attached to the affinity resin and
were dissociated only by treatment with the SDS solubilization
buffer (Fig. 4A). A similar elution profile was observed for PDI
(results not shown). Interestingly, ERp29 was detected even in
the eluates from the nondenatured Tg, although in lower
amounts. Elution of BiP by ATP from the nondenatured matrix
was below the detection level and barely detectable in the SDS
eluate, which is in line with the demonstrated ability of BiP to
interact exclusively with the misfolded substrates (21).
The binding of ERp29 to the Tg-Sepharose beads seems to be
rather specific, because no interaction was observed with the
nondenatured as well as denatured histone-Sepharose (Fig. 4A).
FIG. 4. Binding of ERp29 and BiP to the thyroglobulin and histone affinity resins. A, FRTL-5 cell lysate interacted with the denatured
(with urea and -mercaptoethanol (ME)) or native Tg or histone (His) immobilized on the Sepharose. Retained proteins were eluted with 1 mM ATP
and SDS solubilization buffer subsequently. All of the fractions except SDS were precipitated with acetone, solubilized in the SDS solubilization
buffer, and resolved by 12% SDS-PAGE followed by immunoblotting against ERp29 and BiP. FT, flow-through; Con, control binding of the cell
lysate or microsomal lumen to the blocked BrCN-Sepharose demonstrated absence of the nonspecific binding of the examined proteins to the
Sepharose matrix. B, lumenal fraction of the rat liver microsomes underwent identical affinity binding procedure, and ERp29 was detected as
described above.
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The latter matrix has been previously shown to bind several ER
chaperones including BiP and PDI (15), as was also observed
under our experimental conditions (results not shown).
We also examined interactions with the lumenal fraction
from the rat liver microsomes, which was free from the cellular
components present in the total cell lysate. ERp29 was found
associated with the denatured and to a lesser extent with the
native Tg-Sepharose and eluted only with SDS solubilization
buffer (Fig. 4B). Denatured histone-Sepharose was unable to
retain ERp29 from the lumenal fraction of rat liver microsomes
(Fig. 4B).
ERp29 Co-localizes with Tg—Using immunofluorescence mi-
croscopy we have shown previously a typical ER distribution of
ERp29 in the rat hepatoma cells (3). Immunofluorescent label-
ing of the permeabilized FRTL-5 cells with anti-ERp29 demon-
strated a similar staining pattern (Fig. 5). However, in contrast
to the hepatoma cells, where the staining was stronger in the
perinuclear area, in the hormone-stimulated thyrocytes, addi-
tionally to the extensive staining of the perinuclear region,
ERp29 also exhibited a punctate distribution throughout the
cytoplasm. Double labeling of the same cells with anti-Tg
showed an identical staining pattern, and merging of two flu-
orescent images resulted in the color shift characteristic for
co-localizing proteins (Fig. 5). To establish the extent of the
overlap, we carried out optical sectioning of the double-stained
cells and reconstituted the three-dimensional distribution pat-
terns of ERp29 and Tg using stereo projection of the mathe-
matically deblurred image stacks. This method is much more
sensitive than the laser confocal imaging and allows high res-
olution comparison of the dense fluorescent signals. The im-
ages (Fig. 5) showed a very high degree of spatial co-localiza-
tion of these proteins, apparently in the same vesicular
transport structures.
ERp29 Is Secreted from the Thyrocytes—It has been previ-
ously reported that a number of ER-resident proteins (22–24)
including PDI (Ref. 25 and references therein) are found in the
culture media of the different primary and transformed cell
lines. We examined media collected from the quiescent and
hormone-stimulated cells for the presence of ERp29. Discerni-
ble amounts of the protein were found in the culture medium of
the quiescent cells, which further increased upon the stimula-
tion of cells with the hormonal mixture (Fig. 6A). The relative
amount of ERp29 recovered from the 4-h medium was 11% of
the total (intracellular  secreted) ERp29. This corresponds to
3.5 pmol/2  106 cells as quantified by densitometry of
immunoreactive bands with the calibration curve based on the
serial dilutions of the recombinant ERp29 (results not shown).
Specificity of the ERp29 export was verified by testing media
for the presence of other ER lumenal proteins and mitochon-
drial HSP70. Among all tested proteins, only PDI was recov-
ered from the medium, whereas BiP, GRP94, and mitochon-
drial HSP70 were not secreted (Fig. 6A). The kinetics of the
ERp29 export from FRTL-5 cells is almost identical to the Tg
and PDI secretion (Fig. 6, B and C). We examined medium from
the cells treated with brefeldin A (BFA), the inhibitor of ER-
to-Golgi transport to evaluate any contribution of cell leakage
to the appearance of ERp29 in the medium. In 4 h BFA reduced
the level of secretable ERp29, as well as Tg and PDI, down to
10–30% of the intact cell amounts (Fig. 6B). Additionally, anal-
ysis of the lactate dehydrogenase activity showed that only 1%
of lactate dehydrogenase was released from the cells after 4 h,
whereas ERp29 and PDI levels in the culture medium were
estimated as 10–11% of the total amount.
DISCUSSION
A hypothetical involvement of ERp29 in the processing of the
secretory proteins in the ER was hitherto supported by circum-
stantial evidence, such as co-localization with the ER chaper-
ones and foldases, high expression in the secretory cells (4), and
induction by ER stress (3). The data presented in the current
study demonstrate for the first time that in the professional
secretory cells, such as thyrocytes where the expression of
ERp29 reaches its highest levels (5), ERp29 might be directly
implicated in the process of maturation and secretion of the
main export product of these cells, thyroid prohormone Tg.
The TSH-induced elevation of the ER chaperones in the
thyroid cells is well documented and considered to be a part of
the coordinated cell response to the increased synthesis of Tg
(19, 20). It was suggested that the influx of nascent Tg mole-
cules in the ER triggers the unfolded protein response machin-
ery responsible for the transcriptional activation of the chap-
erone genes (14). We have observed a similar TSH-dependent
up-regulation of ERp29 along with BiP, GRP94, and PDI,
which is also consistent with the previously reported induction
of the ERp29 transcript synthesis (12). Comparable accumula-
tion of the unfolded proteins in the ER (ER stress) caused by
the different agents inhibiting protein glycosylation or altering
calcium homeostasis or redox environment was also found to
stimulate ERp29 biosynthesis in other mammalian cells (3).
It may therefore be speculated that up-regulation of ERp29
by TSH is coupled with the coordinated induction of the ER
chaperones and PDI to maintain or even accelerate the fold-
ing rate of Tg.
FIG. 5. Co-localization of ERp29 and Tg. FRTL-5 cells were fixed,
permeabilized, and double-labeled with the polyclonal anti-ERp29, flu-
orescein isothiocyanate-conjugated anti-rabbit IgGs and monoclonal
anti-TG followed by TRITC-conjugated rabbit anti-mouse IgGs. Three-
dimensional reconstitution of ERp29- and Tg-stained FRTL-5 cells as
reconstituted from a series of nine mathematically deblurred optical
sections 0.2 m apart and projected as a pair of stereoimages. The scale
bar represents 10 m.
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Folding of Tg is accomplished in the large macromolecular
complexes containing simultaneously a number of molecular
chaperones that control the folding state of Tg by repetitive
binding and dissociation until the formation of the transport-
competent, stable Tg dimers (14). Such transient interactions
of molecular chaperones with Tg are usually weak (with the
exception of BiP), and association with Tg is detected only if
augmented by chemical cross-linking (16, 20). Stabilization of
the noncovalent interactions by cross-linking was also essential
for the detection of ERp29 in the Tg- and BiP-containing su-
crose density fractions and in the Tg immunoprecipitates, sug-
gesting the weak and transient nature of ERp29 associations.
Transient binding of molecular chaperones to their substrates
may be expanded if misfolded protein is not able to acquire the
final three-dimensional structure. For instance, prolonged in-
teraction of BiP and GRP94 with the mutant, transport-incom-
petent form of Tg was shown on the mouse model of congenital
goiter (26).
This principle was used to demonstrate physical interaction
of the ER chaperones with their substrates using immobilized
denatured proteins as a bait (15). Reproduction of the same
experimental conditions allowed us to “fish out” ERp29 along
with BiP and PDI from the FRTL-5 cell lysate or purified
lumenal fraction of the rat liver microsomes. At the same time,
certain differences were noted in the ERp29 interaction with
the substrate proteins as compared with BiP or PDI: 1) Unlike
BiP, ERp29 could not dissociate from the Tg-Sepharose upon
ATP elution, which indicates the absence of ATPase activity
characteristic for many chaperones. A similar lack of any ATP
effect was observed also in the co-immunoprecipitation exper-
iments (see “Results”). 2) ERp29 appears to have narrower
substrate specificity as compared with BiP and PDI. This was
exemplified by the absence of binding to the denatured histone-
Sepharose. 3) Despite the preferential association with the
denatured Tg, appreciable amounts of ERp29 have been eluted
also from the native ligand, which is in clear contrast to the
BiP-like discrimination between properly folded and unfolded
substrates and binding almost exclusively to the former. Taken
together, these data indicate a unique mode of interaction of
ERp29 with the substrate protein(s), which is more reminiscent
of features of the chaperones with more narrow substrate spec-
ificity, such as GRP94 (27) or even dedicated escort chaperones,
such as low density lipoprotein receptor-associated protein
(28). The latter remains attached to the receptor even after the
completion of its folding and further escorts it to the cell sur-
face. Interestingly, the interaction of receptor-associated pro-
tein with Tg has been recently demonstrated both in vitro and
in vivo (29). A similar role of the dedicated chaperone was
proposed also for the Drosophila analog of ERp29, Windbeutel
(10, 30).
Although lumenal ER chaperones may leak from the ER,
they are usually recycled back by the ERD2 receptor recogniz-
ing their KDEL (and similar) C-terminal sequence (31). De-
spite the existence of such retrieval mechanism, many lumenal
proteins, such as GRP94, PDI, calreticulin, BiP, and PDI, have
been found in the cell exterior (22–25), and several reports have
proposed possible functional significance of such localization
(25, 32). The instances of the unusual localization of PDI are of
particular interest for this study. ERp29 is a structural homo-
FIG. 6. ERp29 is secreted from the FRTL-5 cells. A, effect of the
hormonal mix on the ERp29 and PDI secretion. FRTL-5 cells were
treated by the hormones (6H) as indicated in the legend to Fig. 1, and
4 h after the change of media, the volumes representing equal amounts
of cells were collected and centrifuged for 10 min at 17,000  g, and
supernatant was concentrated by acetone, resuspended in the SDS
sample buffer, and immunoblotted with corresponding antibodies. The
first lane from the left is a positive control representing cell lysates
immunoblotted with the same antibodies. B, kinetics of ERp29, PDI,
and Tg secretion. The cells were kept in the 6H-supplemented medium,
which was exchanged to the fresh medium, and aliquots representing
equal amounts of cells were collected at the indicated time points,
concentrated, and immunoblotted. 10 g/ml of BFA was added with the
fresh medium. C, results of the densitometric analysis of immunoreac-
tive bands (n  4). Black bars, protein amounts related to the corre-
sponding amounts at 1 h. Gray bars, protein amounts in the presence of
BFA related to the corresponding amounts at 1 h without BFA.
ERp29, a Novel Thyroglobulin Folding/Secretion Factor17014
log of PDI despite the absence of the active site motif, and
because PDI may function also as a general chaperone, it was
proposed that these two proteins might have some overlapping
functions (9). However, extracellular function of PDI may differ
from the ERp29 role, because PDI was found on the surface of
FRTL-5 cells and proposed to react with Tg under acidic con-
ditions (25), whereas our studies in living cells failed to reveal
any cell surface expression of ERp29 (results not shown).
Possible reasons as to how KDEL proteins may escape recy-
cling include saturation of KDEL receptor, defects in the re-
tention system, and proteolytic removal of the C terminus
bearing the retrieval signal (23, 32). It has been previously
shown that overexpression of PDI does not result in the in-
creased secretion of other KDEL proteins (33). In our study,
substantial amounts of ERp29 and PDI were secreted even
from the quiescent cells (Fig. 6). Consequently, the saturation
of recycling mechanisms is not likely to be responsible for the
ERp29 export. Electrophoretic migration of the secreted ERp29
was identical to the migration of the intracellular species,
suggesting similar molecular masses. Extracellular ERp29 was
also recognized by ERp29 antibodies, which were raised
against a peptide from the C-terminal fragment of ERp29 (3)
(results not shown). These data speak in favor of the intact C
terminus of ERp29, available for ERD2 receptor. At the same
time, BFA-regulated export of ERp29 and co-localization of Tg
and ERp29 in the putative transport structures indicate that
ERp29 may proceed via the secretory pathway in a manner
typical for secretory proteins. It was suggested that in certain
cases secretion of KDEL proteins could be triggered by shield-
ing their C-terminal recognition sequence by the substrate
secretory proteins (24). Based on the evidence presented in this
study one can speculate that ERp29 export could occur because
of such association with Tg. Such “co-secretion” is characteris-
tic for so called escort chaperones (34) or molecular escorts (35)
such as receptor-associated protein. Interestingly, the ERp29
analog in Drosophila, Windbeutel, was identified as such ded-
icated escort chaperone, shown to facilitate the transport of its
substrate, Pipe, a putative oligosaccharide-modifying enzyme
essential for embryonic development, to the Golgi (30).
However, despite the demonstrated co-localization of ERp29
and Tg in the cell exterior (Fig. 6A), we failed to detect
ERp29/Tg association in the FRTL-5 cell medium utilizing
immunoprecipitation approach (results not shown). Similarly,
neither BiP nor GRP94 were found in the Tg or ERp29 immu-
nocomplexes. It is worth noting that a similar absence of co-
immunoprecipitating Tg, PDI, and BiP has been shown previ-
ously (25). Nevertheless, because the fate of Tg exported from
the cultivated thyrocytes is quite different from the situation in
the thyroid gland where secreted Tg is stored in the follicular
lumen in form of compact, cross-linked aggregates (36), one
cannot exclude the existence of the extracellular ERp29/Tg
complexes in vivo.
Evidence provided in this work including co-immunoprecipi-
tation studies, sucrose density fractionation, immunofluores-
cent co-localization of ERp29 and Tg, and, finally, affinity iso-
lation of ERp29 on the denatured protein matrix
unambiguously point to the specific association(s) of ERp29
within the multicomponent Tg folding complex in the ER. Al-
though it is tempting to speculate that ERp29 directly interacts
with Tg in a chaperone-like manner, one cannot rule out its
primary association with the other member(s) of the complex.
We have shown, for instance, that BiP may be co-immunopre-
cipitated with ERp29 from the rat hepatoma cells (3). However,
identification of two potential unfolded protein-binding sites in
our recent study (9) may speak in favor of the direct ERp29/Tg
interactions. Given the widespread pattern of ERp29 expres-
sion, similar interactions are anticipated also with the other
secretory proteins, especially in the secretory cells with high
levels of ERp29.
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